Search
Search Results
##search.searchResults.foundPlural##
-
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1238PDF: 648HTML: 7727 -
-
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4115PDF: 1942HTML: 1764 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
999PDF: 537HTML: 7810 -
IMPLEMENTATION OF MICROELIMINATION STRATEGY IN ERADICATION OF CHRONIC HEPATITIS C INFECTION IN PATIENTS WITH HEMOPHILIA IN THE NORTHERN REGION OF SERBIA Microelimination Strategy of Chronic Hepatitis C Infection in patients with Hemophilia
848PDF: 353HTML: 148 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
970PDF: 533HTML: 722 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2184PDF: 1168HTML: 2588Study of serum haptoglobin level in thalassemia: 343Figures: 176 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1613PDF: 989HTML: 357 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4245PDF: 1517HTML: 447 -
PATIENTS WITH HAEMOGLOBINOPATHIES AND CHRONIC HEPATITIS C: A REALLY DIFFICULT TO TREAT POPULATION IN 2016?
2934PDF: 982HTML: 2063Cover letter: 178 -
-
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3879PDF: 1475HTML: 8513 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
3966PDF: 1300HTML: 2261 -
OCCULT HEPATITIS B VIRUS INFECTION AND ASSOCIATED GENOTYPES AMONG HBSAG-NEGATIVE SUBJECTS IN BURKINA FASO
4560PDF: 1183HTML: 486Figure: 218 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1602PDF: 798HTML: 1232Figure 1: 172Figure 2: 188Figure 3: 183 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1337PDF: 764HTML: 508 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1379PDF: 1306HTML: 99 -
-
SEROPOSITIVITY OF HEPATITIS B AND C AMONG SYRIAN MULTITRANSFUSED PATIENTS WITH HEMOGLOBINOPATHY
2959PDF: 741HTML: 1115Cover Letter: 199 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1243PDF: 473HTML: 18570Figure 1: 169Figure 2: 150Figure 3: 167Figure 4: 205Figure 5: 176 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1529PDF: 716HTML: 231 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1566PDF: 847HTML: 1031Picture 1: 168 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3226PDF: 1008HTML: 2024 -
THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia
1014PDF: 865Suppl. Files: 456HTML: 288 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
840PDF: 486HTML: 1303 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2660PDF: 1077HTML: 118 -
PREVENTION OF POST-TRANSFUSION HEPATITIS BY SCREENING OF ANTIBODY TO HEPATITIS B CORE ANTIGEN IN HEALTHY BLOOD DONORS
1155PDF: 682HTML: 1250Title page: 199 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1588PDF: 974HTML: 189 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3192PDF: 1580HTML: 258







